
Neuropace Inc
NASDAQ:NPCE

During the last 3 months Neuropace Inc insiders have not bought any shares, and sold 50.7m USD worth of shares. The stock price has increased by 9% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/npce/vs/indx/gspc">open performance analysis).
The last transaction was made on
Feb 21, 2025
by
Morrell Martha
(Chief Medical Officer)
, who
sold
1.1m USD
worth of NPCE shares.
During the last 3 months Neuropace Inc insiders have not bought any shares, and sold 50.7m USD worth of shares. The stock price has increased by 9% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/npce/vs/indx/gspc">open performance analysis).
The last transaction was made on
Feb 21, 2025
by
Morrell Martha
(Chief Medical Officer)
, who
sold
1.1m USD
worth of NPCE shares.
Neuropace Inc
Glance View
NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. The company is headquartered in Mountain View, California. The company went IPO on 2021-04-22. The firm is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.